OBJECTIVE: To investigate antitumor activity and molecular mechanism of deguelin to the human U937 leukaemia cells and to explore the mechanisms regulating cell cycle and nucleoporin 98 (Nup98) and nucleoporin 88 (Nup88) in vitro. METHODS: The effects of
Chen, WH +5 more
core
Chemotherapeutic potential of deguelin and evaluation of new agents for skin cancer chemoprevention.
Chemotherapeutic potential of deguelin and evaluation of new agents for skin cancer ...
Joell Janette. Gills (7986656)
core +1 more source
Drug combination treatment as a strategy for inhibiting human adenovirus replication. [PDF]
Dodge MJ +6 more
europepmc +1 more source
학위논문 (석사)-- 서울대학교 대학원 : 분자의학 및 바이오제약학과, 2012. 2. 김규원.Deguelin, one compound extracted from several plants, binds ATP-binding site of HSP90 and regulates its activity.
김경석
core
Correction: Deguelin inhibits growth and prolactin synthesis in prolactinomas by targeting the PI3K/AKT/CREB3L1 pathway and ornithine decarboxylase. [PDF]
Gong L +13 more
europepmc +1 more source
Erratum to abnormal neutrophil polarization in chronic obstructive pulmonary disease and how cigarette smoke extracts attract neutrophils. [PDF]
Editorial Office.
europepmc +1 more source
Deguelin inhibits growth and prolactin synthesis in prolactinomas by targeting the PI3K/AKT/CREB3L1 pathway and ornithine decarboxylase. [PDF]
Gong L +13 more
europepmc +1 more source
DEGUELIN ACTION IS THROUGH REGULATION OF ERK-MAPK PATHWAY IN TRIPLE- NEGATIVE BREAST CANCER CELLS
Breast cancer is the most common cancer and the leading cause of cancer related deaths amongst women in the United States. In 15-20% of patients with breast cancer, patients do not express steroid receptors(ER/PR) and do not have amplification of HER2 ...
Katta, Harshadadevi
core
Eccentricity-based topological indices of QSPR modelling using anti-cancer drugs. [PDF]
Vimala R, Ravi Sankar J.
europepmc +1 more source
QSPR analysis of anticancer drugs using the Euler-Sombor index and theoretical insights on its minimum value for unicyclic graphs. [PDF]
Shetty S, Rakshith BR, Udupa NVS.
europepmc +1 more source

